About John Pinion
John Pinion is a chief operations officer at Amlogenyx.
John Pinion reports to the SEC as an officer of 1 public company: Ultragenyx Pharmaceutical (RARE).
John Pinion first appears on SEC filings in 2015.
Experience
This experience comes from John Pinion's profile and from SEC filings. For roles taken from filings, the years are when the filings name John Pinion in the role, so the role may have started earlier or lasted longer.
Amlogenyx Inc. Current
Chief Operations Officer
Chief Operating Officer (2024 – Present)
2024 – Present · Novato, CA
Develops an investigational gene therapy for people with Alzheimer's disease.
CT
Celestial Therapeutics Current
Member Business Advisory Board
2021 – Present
UI
Ultragenyx Pharmaceutical Inc. Current
EVP Translational Sciences, Chief Quality Operations Officer
2015 – Present · Public company (RARE)
AB
Aroa Biosurgery
Member Board of Directors
2015 – 2025
RO
Roche
Global SVP, Global Quality & Compliance
2009 – 2015
GE
Genentech
SVP, Quality & Compliance
2005 – 2009
BI
Baxter International Inc.
VP Quality and Compliance, Baxter Renal Division
1988 – 2005
IT
Imagyn Medical Technology
Director of Quality, Medical Device Manufacturing
1996 – 1997
Key Colleagues at Startups
The people John Pinion works with at each company, as listed on that company's latest Form D.
Amlogenyx Inc. · Form D, Jul 9, 2026
Craig Gordon
Director
Sukumar Nagendran
Director
Emil Kakkis
Founder and Chairman
TH
Ted Huizenga
Executive officer
KP
Karah Parschauer
Executive officer